Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Bod Australia (ASX:BDA) celebrates further growth in June quarter
15 Jul 2021
Published by: The Market Herald
Bod Australia (ASX:BDA) enjoys 212pc increase in product sales over FY21
01 Jul 2021
Published by: The Market Herald
Bod Australia (ASX:BDA) Is In A Good Position To Deliver On Growth Plans
07 Jun 2021
Published by: Simply Wall St News
Bod Australia (ASX:BDA) launches new medicinal cannabis product
18 May 2021
Published by: The Market Herald
Bod (ASX:BDA) share price soars on United States market entry
07 Apr 2021
Published by: The Motley Fool
Healthy revenues make BDA one happy cannabis company
19 Mar 2021
Published by: Switzer Daily
Bod's healthy revenues make it one happy cannabis company
18 Mar 2021
Published by: Business News Australia
Bod's healthy revenues make it one happy cannabis company
18 Mar 2021
Published by: Business News Australia
Bod Australia (ASX:BDA) launches Swisse Wellness CBD products in the Netherlands
20 Oct 2020
Published by: The Market Herald